How Gastrin-Releasing Peptide Opens the Spinal Gate for Itch.


Journal

Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320

Informations de publication

Date de publication:
03 07 2019
Historique:
received: 25 10 2018
revised: 01 03 2019
accepted: 11 04 2019
pubmed: 20 5 2019
medline: 23 10 2019
entrez: 20 5 2019
Statut: ppublish

Résumé

Spinal transmission of pruritoceptive (itch) signals requires transneuronal signaling by gastrin-releasing peptide (GRP) produced by a subpopulation of dorsal horn excitatory interneurons. These neurons also express the glutamatergic marker vGluT2, raising the question of why glutamate alone is insufficient for spinal itch relay. Using optogenetics together with slice electrophysiology and mouse behavior, we demonstrate that baseline synaptic coupling between GRP and GRP receptor (GRPR) neurons is too weak for suprathreshold excitation. Only when we mimicked the endogenous firing of GRP neurons and stimulated them repetitively to fire bursts of action potentials did GRPR neurons depolarize progressively and become excitable by GRP neurons. GRPR but not glutamate receptor antagonism prevented this action. Provoking itch-like behavior by optogenetic activation of spinal GRP neurons required similar stimulation paradigms. These results establish a spinal gating mechanism for itch that requires sustained repetitive activity of presynaptic GRP neurons and postsynaptic GRP signaling to drive GRPR neuron output.

Identifiants

pubmed: 31103358
pii: S0896-6273(19)30379-4
doi: 10.1016/j.neuron.2019.04.022
pmc: PMC6616317
pii:
doi:

Substances chimiques

Grp protein, mouse 0
Potassium Channel Blockers 0
Receptors, Bombesin 0
Receptors, Glutamate 0
Receptors, Presynaptic 0
Gastrin-Releasing Peptide 80043-53-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-117.e5

Subventions

Organisme : European Research Council
ID : 250128
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Science. 2013 May 24;340(6135):968-71
pubmed: 23704570
Mol Pain. 2016 Mar 09;12:
pubmed: 27030718
Neuron. 2006 Apr 6;50(1):89-100
pubmed: 16600858
Pain. 2010 Nov;151(2):475-88
pubmed: 20817353
J Neurophysiol. 2012 Jan;107(1):357-63
pubmed: 21994268
J Physiol. 2014 Feb 15;592(4):759-76
pubmed: 24324003
Pain. 2017 May;158(5):945-961
pubmed: 28157737
Nat Rev Neurosci. 2017 Jul;18(7):389-403
pubmed: 28592905
Brain Res Rev. 2007 Aug;55(1):17-54
pubmed: 17433836
Cell Rep. 2016 Nov 1;17(6):1699-1710
pubmed: 27806306
Nat Neurosci. 2018 May;21(5):707-716
pubmed: 29556030
Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):68-74
pubmed: 21042212
J Neurosci. 2015 Dec 9;35(49):16272-81
pubmed: 26658875
Science. 2009 Sep 18;325(5947):1531-4
pubmed: 19661382
J Physiol. 2002 May 15;541(Pt 1):231-44
pubmed: 12015432
Nat Commun. 2014 Nov 25;5:5540
pubmed: 25420509
Brain Res Brain Res Rev. 2004 Dec;47(1-3):5-17
pubmed: 15572159
J Neurophysiol. 1989 Jul;62(1):96-108
pubmed: 2754484
Mol Pain. 2016 Mar 08;12:
pubmed: 27030714
Mol Pain. 2014 Dec 11;10:79
pubmed: 25496164
Neuron. 2018 Nov 7;100(3):593-608.e3
pubmed: 30293821
Neurosci Lett. 2016 Aug 3;627:51-60
pubmed: 27235577
J Neurosci. 2019 Mar 20;39(12):2238-2250
pubmed: 30655357
Sci Rep. 2017 Nov 13;7(1):15466
pubmed: 29133874
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5789-94
pubmed: 21415372
Mol Pain. 2014 Aug 14;10:44
pubmed: 25123163
Nature. 2007 Aug 9;448(7154):700-3
pubmed: 17653196
Neuron. 2012 Oct 4;76(1):98-115
pubmed: 23040809
J Neurosci. 2015 Jan 14;35(2):648-57
pubmed: 25589759
Neuron. 2010 Nov 4;68(3):543-56
pubmed: 21040853
Pain. 1993 Mar;52(3):341-9
pubmed: 8460052
J Physiol. 2013 Apr 1;591(7):1823-39
pubmed: 23359674
J Neurosci. 2001 Oct 1;21(19):7491-505
pubmed: 11567039
Nat Neurosci. 2013 Feb;16(2):174-82
pubmed: 23263443
Br J Pharmacol. 2009 Apr;156(8):1185-95
pubmed: 19298256
Neuron. 2014 May 7;82(3):573-86
pubmed: 24726382
Pain. 2007 Sep;131(1-2):4-7
pubmed: 17524558
Neuron. 2017 Feb 22;93(4):840-853.e5
pubmed: 28231466
J Neurosci. 1997 Oct 15;17(20):8003-8
pubmed: 9315918
J Neurosci. 2013 Feb 20;33(8):3352-62
pubmed: 23426663
FEBS Lett. 1994 Aug 1;349(2):201-4
pubmed: 8050566
Neuron. 2015 Mar 18;85(6):1289-304
pubmed: 25789756
Neuron. 2010 Mar 25;65(6):886-98
pubmed: 20346763
Eur J Neurosci. 1999 Dec;11(12):4269-77
pubmed: 10594653
Mol Pain. 2011 Jun 24;7:47
pubmed: 21699733
Nat Rev Neurosci. 2007 Jun;8(6):451-65
pubmed: 17514198
Exp Dermatol. 2011 Oct;20(10):778-82
pubmed: 21929688
Nature. 1995 Sep 7;377(6544):62-5
pubmed: 7659162
Pain. 1999 Jan;79(1):67-73
pubmed: 9928778
J Gen Physiol. 2016 Sep;148(3):227-37
pubmed: 27527100
Cell. 2017 Jan 12;168(1-2):295-310.e19
pubmed: 28041852
J Neurosci. 2000 Sep 15;20(18):6773-80
pubmed: 10995820
Nat Commun. 2018 Aug 13;9(1):3230
pubmed: 30104684
J Cell Biol. 1986 Jun;102(6):2211-22
pubmed: 3011811
Mol Pain. 2014 Jan 18;10:4
pubmed: 24438367
Brain Res Mol Brain Res. 2005 Sep 13;139(1):63-79
pubmed: 15936845
Science. 2017 Aug 18;357(6352):695-699
pubmed: 28818946
Neuron. 2002 May 16;34(4):551-62
pubmed: 12062039
Brain Res Mol Brain Res. 2002 Jan 31;98(1-2):153-63
pubmed: 11834308
Pflugers Arch. 2010 Mar;459(4):607-18
pubmed: 19953263
Exp Brain Res. 1980;38(1):1-10
pubmed: 6766107
J Neurosci. 2005 Jul 13;25(28):6490-8
pubmed: 16014710
Pain. 2019 Feb;160(2):442-462
pubmed: 30247267
J Neurophysiol. 2003 Sep;90(3):1671-9
pubmed: 12750419
J Gen Physiol. 2004 Jun;123(6):663-83
pubmed: 15173220

Auteurs

Martina Pagani (M)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Neuroscience Center Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.

Gioele W Albisetti (GW)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Neuroscience Center Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.

Nandhini Sivakumar (N)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.

Hendrik Wildner (H)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.

Mirko Santello (M)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Neuroscience Center Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.

Helge C Johannssen (HC)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.

Hanns Ulrich Zeilhofer (HU)

Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Neuroscience Center Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Drug Discovery Network Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Vladimir-Prelog-Weg 1-5/10, 8090 Zurich, Switzerland. Electronic address: zeilhofer@pharma.uzh.ch.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH